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Epstein-Barr virus (EBV) is associated with about 6 to 16% of gastric carcinoma cases worldwide. Expression
of the EBV microRNAs (miRNAs) was observed in B cells and nasopharyngeal carcinoma cells infected with
EBV. However, it is not clear if the EBV miRNAs are expressed in EBV-associated gastric carcinomas
(EBVaGCs). We found that BART miRNAs but not BHRF1 miRNAs were expressed in EBV-infected gastric
carcinoma cell lines and the tumor tissues from patients as well as the animal model. The expression of viral
miRNAs in EBVaGCs suggests that these EBV miRNAs may play important roles in the tumorigenesis of
EBVaGCs.
About 6 to 16% of gastric carcinoma cases worldwide are
associated with Epstein-Barr virus (EBV) (20). EBV is proposed
to play a causative role in EBV-associated gastric carcinoma
(EBVaGC) as the virus is found in almost all tumor cells and the
viral DNA shows monoclonality in the cancer (11). However, how
EBV causes EBVaGC is unclear because the well-known EBV
oncogenes, such as those coding for LMP1, EBNA2, and
EBNA3s, are not expressed in EBVaGC (14).
MicroRNAs (miRNAs) are 19- to 25-nucleotide-long single-
stranded RNAs processed from transcripts having stem-loop
structures (2, 4, 8). miRNAs have diverse functions, including
the regulation of cellular differentiation, proliferation, and apop-
tosis (1, 3, 15, 21). miRNAs might also function as tumor
suppressors (7, 10) or oncogenes (6, 10, 13).
Pfeffer et al. (19) cloned five EBV miRNAs (miR-BHRF1-1,
miR-BHRF1-2, miR-BHRF1-3, miR-BART1, and miR-
BART2) from Burkitt’s lymphoma cells latently infected with
the B95-8 EBV strain. By Northern blotting, expression of these
EBV miRNAs was confirmed in various B-cell lines. Recently,
two research groups identified additional EBV miRNAs from the
introns of the BART gene (5, 12). The EBV miRNAs may play
important roles in the tumorigenesis of EBVaGC. As a first step
to test this possibility, we have investigated whether the EBV
miRNAs are expressed in EBV-positive gastric carcinoma cell
lines and EBVaGC cases.
Expression of EBV miRNAs in EBV-infected gastric carci-
noma cell lines. The expression profile of EBV miRNAs was
analyzed by Northern blotting in EBV-infected gastric carci-
noma cell lines. SNU-719 is a naturally derived EBV-infected
gastric carcinoma cell line (17, 18), and the green fluorescent
protein (GFP)-expressing cell line AGS-EBV-GFP is an AGS
cell line artificially infected with a recombinant EBV (16).
Previously, we reported that the EBV gene expression pattern
of SNU-719 is uniquely similar to that of EBVaGC (17). Total
RNA was resolved in a 15% polyacrylamide–urea gel before
being transferred to a Zeta-Probe blotting membrane (Bio-
Rad Laboratories, Hercules, CA). Oligonucleotide comple-
mentary to each mature EBV miRNA (12, 19) was end labeled
with [-32P]ATP and T4 kinase. The initially identified five
EBV miRNAs (19) were all expressed in B95-8 as expected
(Fig. 1A). In contrast, SNU-719 and AGS-EBV-GFP ex-
pressed only miR-BART1 and miR-BART2 between them.
Similar to other reports (19), the expression level of miR-
BART2 was very low compared with that of miR-BART1. In
addition to the mature miRNAs, the EBV pre-miRNAs were
also detected sometimes, but not always (data not shown).
The majority of the newly identified EBV miRNAs (5, 12)
are located within the region deleted in the B95-8 EBV strain
(Fig. 1B). Among the newly identified EBV miRNAs, miR-
BART3, miR-BART5, miR-BART7, miR-BART10, and miR-
BART12 were chosen to examine their expression. SNU-719
and AGS-EBV-GFP expressed all of the newly identified
BART miRNAs, while B95-8 did not express any of them
except miR-BART3 (Fig. 1A).
To clarify that the failed detection of BHRF1 miRNAs in
the gastric carcinoma cell lines was not due to variances in the
EBV strains, sequences around these miRNAs were analyzed.
Even though there were 10 nucleotide changes in SNU-719
compared with B95-8, the sequences of the putative pre-
BHRF1 miRNAs of SNU-719 were the same as those of B95-8
(data not shown). Thus, EBV miRNAs seem to be differen-
tially regulated in different EBV-infected cell lines.
Expression profile of EBV miRNAs in an EBVaGC animal
model. Four-week-old female athymic nude mice (BALB/c
nu/nu) were purchased from Japan SLC, Inc. (Hamamatsu,
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Japan), and were maintained under specific-pathogen-free
conditions. SNU-719 cells were injected subcutaneously into a
flank of the mouse. All of the animal experiments were per-
formed according to the Guidelines for the Care and Use of
Laboratory Animals of the Catholic University of Korea. Tu-
mor was induced 40 to 45 days after the inoculation and
showed similar characteristics of EBVaGCs (Sang Taek Oh et
al., unpublished data). Four tumor-bearing nude mice were
sacrificed to analyze the expression pattern of EBV miRNAs.
The tumors expressed all of the tested BART miRNAs but not
any of the BHRF1 miRNAs (Fig. 2). miR-BART2 was detect-
able at a low level only after X-ray film had been exposed for
an extended period (data not shown). A relatively higher level
of expression of BART miRNAs was noticable for tumors
compared with the injected SNU-719 cells. Elevated BART
miRNA expression was also observed in a nasopharyngeal
carcinoma (NPC) tumor passaged in nude mice (C15) com-
pared with that in an NPC cell line (5).
Expression of EBV miRNAs in human gastric carcinoma
tissues. Paraffin-embedded human gastric carcinoma tissues
were procured in accordance with the Institutional Review
Board Policies of the Catholic University of Korea. To select
EBVaGC cases, in situ hybridization for EBER was carried out
(Fig. 3A) (17). Four EBER-positive (G7 to G10) and six EBER-
negative (G1 to G6) gastric carcinoma cases were chosen for
analysis. RNA was purified from 200-m-thick slices of the EB-
VaGC paraffin block. The obtained total RNAs (12 to 57 g)
were used at once without normalizing the amounts. On the gel,
distinct 5S rRNA bands were visible from the control cell lines,
but the RNA samples from the tumor tissues appeared as smears
FIG. 1. Expression profile of EBV miRNAs in EBV-infected gastric carcinoma cell lines. (A) Northern blot for EBV miRNAs using total RNA
isolated from gastric carcinoma cell lines. An EBV-positive B-cell line, B95-8, was used as a positive control. An EBV-negative gastric carcinoma
cell line, AGS, was included as a negative control. The quality and quantity of the loaded RNA were assessed by reprobing the blot for U6 snRNA.
The expression of human miR-16 was assessed as a reference. Blots were stripped and reprobed several times. Before reprobing, complete stripping
of the blot was confirmed by exposing the membrane to film for a week. (B) Locations of the EBV miRNAs. The top panel shows the position
of the latent genes and promoters (arrows). The lower panels show the position of the EBV miRNAs, which are marked as gray boxes.
FIG. 2. Expression profile of EBV miRNAs in an EBVaGC animal
model. Total RNA was resolved in a gel and transferred to a mem-
brane. Each mature EBV miRNA was hybridized with a specific probe
labeled with [-32P] ATP. Akata-EBV was used as a positive control
for BART miRNAs, and LCL1 was used as a positive control for
BHRF1 miRNAs. BJAB was used as a negative control. The loading
amount for each RNA sample was monitored by Northern blotting of
U6 snRNA. Blots were stripped and reprobed several times. Before
reprobing, complete stripping of the blot was confirmed by exposing
the membrane to film for a week.
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except for the G4 tumor, in which a faint 5S rRNA band was
detectable (data not shown). Extended storage of the paraffin
blocks at room temperature as well as the fixing process of the
tumor tissue might have resulted in degradation of RNA.
In spite of the poor RNA quality, we could detect miR-
BART1 and miR-BART2 expression in all of the EBVaGC
cases (Fig. 3B). BHRF1 miRNAs were undetectable in any of
the tumor tissues, similar to what was observed for the EBV-
positive gastric carcinoma cell lines (Fig. 3B) (data not shown).
To analyze the expression pattern of the newly identified
BART miRNAs, additional gastric carcinoma cases were
screened (data not shown) and one EBV-positive and two
EBV-negative cases were selected. The quality of the purified
RNA from the tumor tissues was not good, as judged from the
U6 snRNA bands. However, miR-BART5, miR-BART7, and
miR-BART10 were detected in the EBVaGC case as well as in
the Jijoye cell line (Fig. 3C). After prolonged exposure, miR-
BART 12 was detected in the EBV-positive tumor tissue but
FIG. 3. Expression of EBV miRNAs in the gastric carcinoma tissues. (A) The gastric carcinoma tissues were fixed and hybridized with an
EBER-specific DNA probe. Under a light microscope, positive staining was observed as black granules at the site of hybridization (original
magnification, 200). (B) Northern blotting for EBV miR-BART1, miR-BART2, and miR-BHRF1-2 was performed. The expression of human
miR-16 was assessed for comparison. The loading amount for each RNA sample was monitored by Northern blotting of U6 snRNA. All of the
data were obtained using one blot. Before reprobing, complete stripping of the blot was confirmed by exposing the membrane to film for a week.
G1 to G10, gastric carcinoma tissues. (C) Northern blotting for EBV miR-BART5, miR-BART7, miR-BART10, and miR-BART12 was performed
as described above.
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not in Jijoye cells (Fig. 3C). This may be due to its limited
expression in B cells, as shown in Fig. 1 and Fig. 2 as well as in
other reports (5, 12).
Unlike in the control cell lines, miR-16 was undetectable in
all the tumor samples except tumor G4 (Fig. 3B). This can be
explained by the poor RNA quality or by frequent deletion and
down-regulation of miR-16 in some tumors (7).
As many EBV miRNAs including some BART miRNAs are
evolutionally conserved, they are expected to play important
roles in the viral life cycle (5, 9). It is puzzling that B95-8 shows
full transforming activity and viral production in vitro, even
though the majority of BART miRNAs are deleted in B95-8.
BART miRNAs may play important roles in EBV-induced
epithelial cell transformation but not in B-cell transformation.
Or BART miRNAs could be essential for cell survival in vivo
but dispensable in vitro. The highly expressed BART miRNAs
may play important roles in immune evasion of the EBV-
associated epithelial tumors in vivo. These EBV miRNAs may
also support cell proliferation or suppress apoptosis under low
oxygen tension found inside the tumor tissue. To clarify the
role of EBV miRNAs in EBV-associated tumors, further re-
search is warranted.
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